EGb 761 vs Generic "24%/6%" Ginkgo: The Extract That Was Studied
Educational summary — not medical advice. Even the trial extract has modest, narrow evidence; this page is about which product matches the studied material, not a claim that it works.
The short answer
Every ginkgo trial that showed anything used one extract: EGb 761 (Dr. Willmar Schwabe), standardized to ~24% flavone glycosides, ~6% terpene lactones, and <5 ppm ginkgolic acids (van Beek 2009). A generic "24%/6%" extract prints the same two numbers — identical on paper — but isn't the trial material. A whole-leaf product is unstandardized and furthest from it. And ginkgolic acids — allergenic, cytotoxic contaminants pharmacopeias cap at <5 ppm (Boateng 2022) — are almost never disclosed: of 11 products, only 2 generics print a figure. 2 are the EGb 761 extract.
The three tiers of "ginkgo," side by side
| Tier | What it is | Standardization | Tied to the trials? |
|---|---|---|---|
| EGb 761 | The Schwabe trial extract (Nature's Way Ginkgold / Ginkgold Max) | 24% / 6% and <5 ppm ginkgolic acids (inherent to spec) | Yes — the studied material |
| Generic "24% / 6%" | A standardized ginkgo extract from any manufacturer | 24% / 6% on the label; ginkgolic acids usually unstated | Looks identical, but isn't EGb 761 |
| Whole-leaf | Unstandardized leaf / high "equivalency" (e.g. 50:1, "6,000 mg equiv") | None — actives & contaminants unknown | No — furthest from the trials |
Why "24% / 6%" on two labels doesn't mean the same product
Here's the trap. EGb 761 defined the standardization the field now uses — roughly 24% flavone glycosides and 6% terpene lactones. Generic manufacturers print those same two numbers, so a $9 bottle and the trial extract can look identical on the Supplement Facts panel. But matching two headline percentages isn't the same as being the trial material: the specific terpene profile, the manufacturing consistency, and — critically — the ginkgolic-acid control aren't guaranteed to match. Every positive ginkgo result was generated with EGb 761 specifically (Tan 2015; Gauthier 2014), so "24%/6%" is a necessary sign you have a standardized extract, not sufficient proof you have the studied one.
The ginkgolic-acid disclosure test
Ginkgolic acids are the primary source of ginkgo's safety concerns — allergenic and cytotoxic — which is why pharmacopeias limit them to <5 ppm in finished extracts (Boateng 2022). Keep the claim bounded: they're cytotoxic at higher concentrations but were not mutagenic in the assays tested (Berg 2015), so this is a contaminant to limit, not a proven genotoxin to fear. The real-world problem is disclosure: almost no product tells you its level. In our set, only the generics Doctor's Best Extra Strength Ginkgo Biloba 120 mg (120 Veggie Caps) (<5 ppm) and Life Extension Ginkgo Biloba Certified Extract 120 mg (365 Veg Caps) (<1 ppm) print an actual figure. The EGb 761 products carry the <5 ppm ceiling inherently, as part of the extract specification (van Beek 2009) — so counting both, 4 of 11 have a known ginkgolic-acid ceiling and the rest are a black box.
Put together Two filters. First, is it the trial extract (EGb 761), or at least a genuine standardized 24%/6% — not whole-leaf? Second, is the ginkgolic-acid limit known — disclosed on the label, or inherent to EGb 761? Of 11 products we track, 2 are EGb 761 and only 2 generics disclose a ginkgolic-acid figure. Most standardized ginkgo passes the first filter on paper and fails the second.
Whole-leaf and "equivalency" numbers: the furthest from the evidence
The tier to be most skeptical of is unstandardized whole-leaf, often sold with a big equivalency number like "6,000 mg equivalent" from a 50:1 concentrate. That number describes starting leaf weight, not active content: you don't know the flavone-glycoside or terpene-lactone percentage, and you have no assurance the ginkgolic acids are controlled. Since no ginkgo trial used whole leaf, it's the version least connected to whatever modest evidence exists.
What to actually do
- Want the studied material? Buy EGb 761. In the US that's Nature's Way Ginkgold or Ginkgold Max — the only products matching the trial extract.
- Going generic? Prefer one that discloses ginkgolic acids. A disclosed <5 or <1 ppm figure is the one quality signal a generic can give you.
- Don't treat "24% / 6%" as proof. It's necessary, not sufficient — the same two numbers appear on the trial extract and a $9 generic.
- Skip whole-leaf and big "equivalency" numbers if you care about matching the evidence — they're unstandardized and uncontrolled.
As an Amazon Associate we earn from qualifying purchases. Tiered by extract identity and ginkgolic-acid disclosure, never commissions.
Frequently asked questions
EGb 761 vs generic ginkgo?
EGb 761 is the Schwabe extract the trials used (Nature's Way Ginkgold / Ginkgold Max); generic "24%/6%" prints the same numbers but isn't the trial material and rarely controls ginkgolic acids. Identical on paper, not identical in the bottle.
What are ginkgolic acids?
Allergenic, cytotoxic contaminants pharmacopeias cap at <5 ppm (Boateng 2022). Cytotoxic but not mutagenic in tested assays (Berg 2015) — a contaminant to limit, not a proven genotoxin. Only 2 generics we track disclose a figure.
Is whole-leaf as good as an extract?
No — it's unstandardized, its actives and ginkgolic acids are unknown, and no trial used whole leaf. A standardized 24%/6% extract (ideally EGb 761) is the only version tied to the evidence.
Does "24% / 6%" mean it's the studied extract?
No. Those are the standardization targets EGb 761 set, and generics print them too. Matching them doesn't make a product EGb 761, and it says nothing about ginkgolic-acid control.
Related
- Ginkgo: the honest overview — why the independent evidence is null
- Best ginkgo — every product grouped by quality tier, with cost per serving
- Ginkgo dosage guide — 120–240 mg/day + a dose calculator
- Does ginkgo work? — the null, the narrow EGb 761 signal, and the safety
Sources
- van Beek TA, Montoro P. "Chemical analysis and quality control of ginkgo biloba leaves, extracts, and phytopharmaceuticals." J Chromatogr A. 2009. PMID: 19195661 (EGb 761 spec: 24%/6%, ginkgolic acids ~5 ppm).
- Boateng ID. "A critical review of ginkgolic acids in ginkgo biloba." Food Funct. 2022. PMID: 36065842 (ginkgolic acids = primary adverse source; pharmacopeia <5 ppm).
- Berg K, et al. "Genotoxicity and toxicity of ginkgolic acids." Toxicology. 2015. PMID: 25448085 (cytotoxic ≥50 µM but not mutagenic in these assays).
- Tan MS, et al. "Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia." J Alzheimers Dis. 2015. PMID: 25114079 (EGb 761 240 mg).
- Gauthier S, Schlaefke S. "Efficacy and tolerability of ginkgo biloba extract EGb 761 in dementia." Clin Interv Aging. 2014. PMID: 25506211 (manufacturer-affiliated — disclosed).
- Full product dataset: /ginkgo/cost-by-brand.json (CC BY 4.0).